Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Hickey Benjamin Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 22,297 shares @ $37, valued at $825k
01/24/2023 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 36,394 shares @ $0
Granted 45,456 options to buy @ $45.66, valued at $2.1M
01/19/2023 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 947 shares @ $42.3779, valued at $40.1k
Sold 619 shares @ $42.3814, valued at $26.2k
01/10/2023 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 2,088 shares @ $45.37, valued at $94.7k
12/21/2022 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 19,149 shares @ $0
Sold 3,248 shares @ $40.4143, valued at $131.3k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2022 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 10,755 shares @ $0
Sold 627 shares @ $120.4828, valued at $75.5k
Granted 17,821 options to buy @ $124.31, valued at $2.2M
01/07/2022 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 1,964 shares @ $135.9389, valued at $267k
01/05/2022 4 Hickey Benjamin (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Granted 24,000 options to buy @ $5.08, valued at $121.9k
03/22/2021 4 Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 588 shares @ $175.5367, valued at $103.2k
Sold 1,350 shares @ $176.4229, valued at $238.2k
Sold 431 shares @ $177.7056, valued at $76.6k
Exercised 2,369 options to buy @ $114.33, valued at $270.8k
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2019 4 Hickey Benjamin (SVP, Chief Commerical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 6,990 shares @ $15.46, valued at $108.1k
Exercised 20,216 restricted stock units @ $0
02/14/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy